NCT05750485

Brief Summary

Procedural sedation involves the administration of sedative medications that allow patients to tolerate painful procedures. Procedural sedation has been formally recommended by experts from the French Society of Emergency Medicine (SFMU) since 2010 and procedural sedation using propofol in emergency departments has been recommended by the American College of Emergency Physicians in 2018. Propofol monotherapy is now widely used in emergency medicine (EM) in France as part of procedural sedation for performing painful procedures, however propofol has no analgesic properties per se . Pupilometry makes it possible to study the depth of analgesia by evaluating the body's nociceptive response via the ANS by studying the pupil diameter. This technique would allow the evaluation of the analgesia level in patients sedated by PROPOFOL during the realization of painful procedures. Variations in pupil diameter during painful procedures under procedural sedation in an emergency department will be assesed in this study. Secondly, patients satisfaction following the procedure will also be evaluated by the use of the French version of the "ISAS-F", the Iowa Satisfaction with Anesthesia Scale.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 7, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 1, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

March 6, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

April 8, 2025

Status Verified

April 1, 2025

Enrollment Period

3 months

First QC Date

February 7, 2023

Last Update Submit

April 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • pupil dilation reflex

    Amplitude of pupil dilation reflex (PRD, in % change in pupil diameter)

    up to 10 minutes

Secondary Outcomes (7)

  • Pupil diameter using the Algiscan device

    up to 10 minutes

  • Pupil diameter variation using the Algiscan

    up to 10 minutes

  • Heteroevaluation of the patient's maximal pain

    up to 10 minutes

  • Patient's minimal Ramsay score

    up to 10 minutes

  • Level of sedation

    up to 10 minutes

  • +2 more secondary outcomes

Study Arms (1)

Pupilometric evaluation under procedural sedation with propofol

Other: Pupilometric evaluation

Interventions

Pupilometric evaluation under procedural sedation with propofol

Pupilometric evaluation under procedural sedation with propofol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients admitted at vital emergency room, consecutive to an orthopedic trauma, for the performance of a painful procedure under procedural sedation with PROPOFOL.

You may qualify if:

  • Adult patients
  • patient admitted at vital emergency room,
  • patient with an orthopedic trauma,
  • patient under procedural sedation with PROPOFOL.

You may not qualify if:

  • Patient's refusal of pupilometry measurement.
  • Pre-existing pupil abnormalities.
  • history of pathologies with dysautonomic impairment (advanced diabetes, systemic amyloidosis, multiple sclerosis, uncontrolled hypertension, ...).
  • Recent administration of Metoclopramide, Droperidol, Clonidine, Dexmedetomidine
  • Nitrous oxide prior to procedural sedation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nice University Hospital

Nice, 06000, France

Location

MeSH Terms

Conditions

Musculoskeletal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2023

First Posted

March 1, 2023

Study Start

March 6, 2023

Primary Completion

May 31, 2023

Study Completion

May 31, 2023

Last Updated

April 8, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations